Fabry disease: the importance of the enzyme replacement therapy (TRE), treating quickly and efficiently

Fabry disease: the importance of the enzyme replacement therapy (TRE), treating quickly and efficiently

Fabry Disease is a lysosomal disorder due to the absence or deficiency of the Alpha galactosidase A enzyme that causes a pathological accumulation of glycosphingolipids mainly in the endothelial cells, vascular smooth muscle cells and podocytes among others. Enzyme replacement therapy is the only op...

Full description

Bibliographic Details
Main Authors: Juan Manuel Politei, Andrea B. Schenone, Norberto Antongiovanni, Ana María Cusumano, Gustavo Cabrera, Marina Szlago
Format: Article
Language:Spanish
Published: Asociación Regional de Diálisis y Trasplantes Renales de Capital Federal y Provincia de Buenos Aires 2014-06-01
Series:Revista de Nefrología, Diálisis y Trasplante
Subjects:
enfermedad de Fabry
terapia reemplazo enzimático
Agalsidasa Beta
podocito
lisosoma
dolor neuropático
Online Access:http://www.revistarenal.org.ar/index.php/rndt/article/view/108

Internet

http://www.revistarenal.org.ar/index.php/rndt/article/view/108

Similar Items